EUVIMEDEUVIMED entdecken
Crossref

Exogenous putrescine supplementation improves cyclophosphamide-induced premature ovarian insufficiency in mice

Chenxi Zhao iD, Cong Xu, Qian Zhang, Yuyi Wang, Siyuan Xie, Chao Gao, Yugui Cui, Wei Wu iD

Molecular Human Reproduction · 11.04.2026 · 32 (2)

DOI: 10.1093/molehr/gaag018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Human Reproduction, online erschienen am 30.03.2026. Verfasst von Chenxi Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanji…. Hauptthemen laut MEDLINE: Cyclophosphamide, Primary Ovarian Insufficiency, Putrescine. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Nature and Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of premature ovarian insufficiency (POI) is gradually increasing, and currently, no clinical treatments are available to restore ovarian function in POI patients, which severely affects the physical and mental health of young women with fertility needs. Putrescine is a type of polyamine found in the human body and different foods, and research has shown that adding putrescine to drinking water can reduce embryo resorption rates in aged mice. Polyamines are also closely related to apoptosis, with ovarian granulosa cell (GC) apoptosis considered an important factor in follicular atresia, which may lead to POI. Therefore, we investigated putrescine’s actions in POI. We generated a drug-induced POI mouse model by intraperitoneally injecting cyclophosphamide (Cy) into animals. Putrescine was then added to their drinking water to explore its effects on ovarian function in mice. In vitro, we added 4-hydroxycyclophosphamide and putrescine to a GC line to examine the specific mechanisms underpinning putrescine actions. We discovered that putrescine improved ovarian function and fertility in Cy-induced POI mice and ameliorated GC apoptosis via P53 signaling. These findings provide potential therapeutic strategies for patients with POI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamidePrimary Ovarian InsufficiencyPutrescineAnimalsFemaleApoptosisMiceGranulosa CellsTumor Suppressor Protein p53Disease Models, AnimalOvarySignal Transduction

Stichwörter der Autor:innen

P53apoptosiscyclophosphamidefertilitygranulosa cellspremature ovarian insufficiencyputrescine

Substanzen

CyclophosphamidePutrescineTumor Suppressor Protein p53

Autor:innen und Institutionen

  • State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
  • School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

ORCID-Profile: Chenxi Zhao, Wei Wu

Förderung

  • National Nature and Science Foundation of China

Zitieren

APA

Zhao, C., Xu, C., Zhang, Q., Wang, Y., Xie, S., Gao, C., Cui, Y., & Wu, W. (2026). Exogenous putrescine supplementation improves cyclophosphamide-induced premature ovarian insufficiency in mice. Molecular Human Reproduction, 32(2). https://doi.org/10.1093/molehr/gaag018

Vancouver

Zhao C, Xu C, Zhang Q, Wang Y, Xie S, Gao C, et al. Exogenous putrescine supplementation improves cyclophosphamide-induced premature ovarian insufficiency in mice. Molecular Human Reproduction. 2026;32(2). doi:10.1093/molehr/gaag018

BibTeX
@article{Zhao2026,
  author = {Zhao, Chenxi and Xu, Cong and Zhang, Qian and Wang, Yuyi and Xie, Siyuan and Gao, Chao and Cui, Yugui and Wu, Wei},
  title = {Exogenous putrescine supplementation improves cyclophosphamide-induced premature ovarian insufficiency in mice},
  journal = {Molecular Human Reproduction},
  year = {2026},
  volume = {32},
  number = {2},
  doi = {10.1093/molehr/gaag018}
}
Kostenlos starten →